Intramyocellular triacylglycerol accumulation across weight loss strategies; Sub-study of the CENTRAL trial

DSpace/Manakin Repository

Intramyocellular triacylglycerol accumulation across weight loss strategies; Sub-study of the CENTRAL trial

Citable link to this page

 

 
Title: Intramyocellular triacylglycerol accumulation across weight loss strategies; Sub-study of the CENTRAL trial
Author: Gepner, Yftach; Shelef, Ilan; Schwarzfuchs, Dan; Cohen, Noa; Bril, Nitzan; Rein, Michal; Tsaban, Gal; Zelicha, Hila; Yaskolka Meir, Anat; Tene, Lilac; Sarusy, Benjamin; Rosen, Philip; Hoffman, Jay R.; Stout, Jeffrey R.; Thiery, Joachim; Ceglarek, Uta; Stumvoll, Michael; Blüher, Matthias; Stampfer, Meir J.; Shai, Iris

Note: Order does not necessarily reflect citation order of authors.

Citation: Gepner, Y., I. Shelef, D. Schwarzfuchs, N. Cohen, N. Bril, M. Rein, G. Tsaban, et al. 2017. “Intramyocellular triacylglycerol accumulation across weight loss strategies; Sub-study of the CENTRAL trial.” PLoS ONE 12 (11): e0188431. doi:10.1371/journal.pone.0188431. http://dx.doi.org/10.1371/journal.pone.0188431.
Full Text & Related Files:
Abstract: Background: Intramyocellular triacylglycerol (IMTG) is utilized as metabolic fuel during exercise and is linked to insulin resistance, but the long-term effect of weight loss strategies on IMTG among participants with abdominal fat, remain unclear. Methods: In an 18-month trial, sedentary participants with abdominal fat/dyslipidemia were randomized to either a low-fat (LF) or Mediterranean/low-carbohydrate (MED/LC) diet (including 28g·day-1 of walnuts). After 6-months, the participants were re-randomized to moderate intense physical activity (PA+) or non-physical activity (PA-). Magnetic resonance imaging (MRI) was used to quantify changes of IMTG, abdominal sub-depots, hepatic and intermuscular fats. Results: Across the 277 participants [86% men, age = 48 years, body-mass-index (BMI) = 31kg/m2, visceral fat = 33%] 86% completed the 18-m trial. At baseline, women had higher IMTG than men (3.4% vs. 2.3%, p<0.001) and increased IMTG was associated with aging and higher BMI, visceral and intermuscular fats, HbA1c%, HDL-c and leptin(p<0.05), but not with intra-hepatic fat. After 18 month of intervention and a -3 kg mean weight loss, participants significantly increased IMTG by 25%, with a distinct effect in the MED/LCPA+ group as compared to the other intervention groups (57% vs. 9.5–18.5%, p<0.05). Changes in IMTG were associated with visceral and intermuscular fat, metabolic syndrome, insulin and leptin (p<0.05 for all), however, these associations did not remain after adjustment for visceral fat changes. Conclusions: Lifestyle strategies differentially affect IMTG accumulation; combination of exercise with decreased carbohydrate/increased unsaturated fat proportion intake greatly increase IMTG. Our findings suggest that increased IMTG during diet-induced moderate weight loss may not be directly related to cardiometabolic risk. Trial registration ClinicalTrials.gov NCT01530724
Published Version: doi:10.1371/journal.pone.0188431
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708655/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:34651960
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters